CR11509A - Polvo nutricional estable - Google Patents

Polvo nutricional estable

Info

Publication number
CR11509A
CR11509A CR11509A CR11509A CR11509A CR 11509 A CR11509 A CR 11509A CR 11509 A CR11509 A CR 11509A CR 11509 A CR11509 A CR 11509A CR 11509 A CR11509 A CR 11509A
Authority
CR
Costa Rica
Prior art keywords
nutritional powder
stable nutritional
stable
lecithin
oils
Prior art date
Application number
CR11509A
Other languages
English (en)
Inventor
Jeffrey M Boff
Christine L Clinger
Marti Bergana
Paul W Johns
Gary E Katz
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of CR11509A publication Critical patent/CR11509A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Dairy Products (AREA)

Abstract

Los datos colectivos de los estudios demuestran que la proteina de caseina hidrolizada en combinacion con la lecitina segun se describe aqui, suministra un efecto antioxidante sinergico tanto en una matriz de mezcla de aceites como de polvo nutricional
CR11509A 2007-12-20 2010-06-17 Polvo nutricional estable CR11509A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1531207P 2007-12-20 2007-12-20

Publications (1)

Publication Number Publication Date
CR11509A true CR11509A (es) 2010-12-16

Family

ID=40788960

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11509A CR11509A (es) 2007-12-20 2010-06-17 Polvo nutricional estable

Country Status (26)

Country Link
US (1) US8361534B2 (es)
EP (1) EP2227099B1 (es)
JP (1) JP2011507517A (es)
CN (1) CN101998835A (es)
AR (1) AR069839A1 (es)
AU (1) AU2008343687A1 (es)
BR (1) BRPI0823502A2 (es)
CA (1) CA2708272C (es)
CL (1) CL2008003807A1 (es)
CO (1) CO6280446A2 (es)
CR (1) CR11509A (es)
DK (1) DK2227099T3 (es)
DO (1) DOP2010000174A (es)
EC (1) ECSP10010261A (es)
ES (1) ES2535144T3 (es)
GT (1) GT201000174A (es)
IL (1) IL206200A (es)
MX (1) MX2010006891A (es)
MY (1) MY150500A (es)
NZ (1) NZ585574A (es)
PA (1) PA8808801A1 (es)
PE (1) PE20091454A1 (es)
RU (1) RU2479219C2 (es)
TW (1) TWI418308B (es)
WO (1) WO2009085386A2 (es)
ZA (1) ZA201004029B (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1973406B1 (en) 2005-12-28 2014-03-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
CA2673120C (en) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
US9623094B2 (en) 2009-03-27 2017-04-18 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
CN107233337A (zh) 2009-04-29 2017-10-10 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法
SI2424356T1 (en) 2009-04-29 2018-01-31 Armarin Pharmaceuticals Ireland Limited A stable pharmaceutical composition and procedures for its use
KR101799983B1 (ko) * 2009-05-26 2017-12-20 어드밴스드 바이오뉴트리션 코프. 생물학적 활성 미생물 및/또는 생활성 물질을 포함하는 안정한 건식분말 조성물 및 제조 방법
WO2010147994A1 (en) 2009-06-15 2010-12-23 Amarin Pharma, Inc. Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
TW201112967A (en) * 2009-09-16 2011-04-16 Abbott Lab Dryblended nutritional powders
MX2012003555A (es) 2009-09-23 2012-07-03 Amarin Corp Plc Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma.
WO2011094469A2 (en) 2010-01-28 2011-08-04 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
CL2011001984A1 (es) 2010-08-13 2012-06-29 Advanced Bionutrition Corp Composicion seca estabilizadora para material biologico que comprende carbohidrato, proteinas hidrolizadas de animal o de planta y un componente de acido carboxilico; metodo de preparacion; y formulacion de entrega oral que comprende la composicion seca estabilizadora.
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
NZ727980A (en) 2010-11-29 2018-08-31 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
TWI561175B (en) * 2011-03-31 2016-12-11 Meiji Co Ltd Flowable nutrition composition containing l-arginine and method for producing the same
US20120269929A1 (en) * 2011-04-22 2012-10-25 Hugh Lippman Fortified Milk-Based Nutritional Compositions
CN103889253A (zh) * 2011-08-16 2014-06-25 雅培制药有限公司 超声能量在营养粉制备中的应用
CN103957725A (zh) 2011-09-20 2014-07-30 雅培制药有限公司 包含喷雾干燥的植物蛋白的粉末状营养组合物
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
EP2775837A4 (en) 2011-11-07 2015-10-28 Amarin Pharmaceuticals Ie Ltd METHODS OF TREATING HYPERTRIGLYCERIDEMIA
ES2891473T3 (es) 2012-01-06 2022-01-28 Amarin Pharmaceuticals Ie Ltd Composiciones y métodos para reducir los niveles de alta sensibilidad (hs-CRP) en un sujeto
EP3815684B1 (en) 2012-06-29 2024-09-04 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US20140328970A1 (en) * 2013-05-03 2014-11-06 Mead Johnson Nutrition Company Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10639334B2 (en) * 2014-01-07 2020-05-05 Mead Johnson Nutrition Company Pediatric nutritional composition with milk peptides for healthy growth and development
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
CN106659223A (zh) * 2014-07-21 2017-05-10 雅培制药有限公司 具有特定抗氧化剂的营养粉末
MX2017004582A (es) * 2014-10-08 2017-10-12 Abbott Lab Composiciones nutricionales que comprenden un componente oxidable y un extracto de plantas solubles en agua.
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
BR112018001784B1 (pt) 2015-07-29 2022-05-10 Advanced Bionutrition Corp Composições probióticas secas estáveis para usos dietéticos especiais, seu método de preparação e método de preparação de uma fórmula para bebês
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
WO2019090093A1 (en) * 2017-11-03 2019-05-09 Advanced Bionutrition Corp. Composition containing viable microorganisms and methods of making
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
ES2983568T3 (es) 2018-09-24 2024-10-23 Amarin Pharmaceuticals Ie Ltd Métodos para reducir el riesgo de eventos cardiovasculares en un sujeto
EP4058141A4 (en) 2019-11-12 2023-11-22 Amarin Pharmaceuticals Ireland Limited METHOD FOR REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT WITH Atrial fibrillation and/or atrial flutter
AU2022263358A1 (en) 2021-04-21 2023-11-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830861A (en) * 1988-07-14 1989-05-16 Bristol-Myers Company Low manganese high protein rice flour
US5013569A (en) * 1990-05-21 1991-05-07 Century Laboratories, Inc. Infant formula
US5021245A (en) * 1990-05-22 1991-06-04 Abbott Laboratories Infant formula containing a soy polysaccharide fiber source
US5405637A (en) * 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
NZ331481A (en) * 1994-01-10 2000-02-28 Abbott Lab Infant formula with a specific fat blend of soy, coconut, and high oleic safflower oil (HOSO), or a specified fatty acid profile of lauric, palmitic, oleic, or linleic acid
US6136858A (en) * 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
JP3878690B2 (ja) * 1995-09-29 2007-02-07 森永乳業株式会社 乳幼児用乳糖含有食品組成物
ATE265207T1 (de) * 1997-02-21 2004-05-15 Abbott Lab Verwendung von mehrfach ungesättigten fettsäuren zur vorbeugung von nekrotizierender enterokolitis
EP1034704A1 (en) * 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US6365218B1 (en) * 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6207638B1 (en) * 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
ES2291406T3 (es) * 2001-11-26 2008-03-01 Nestec S.A. Composicion nutritiva auto-estable, que contiene proteina de suero lacteo, intacta, procedimiento de fabricacion y uso.
RU2262867C2 (ru) * 2002-02-14 2005-10-27 Катков Юрий Адольфович Бад к пище для улучшения репродукции человека (варианты)
TWI317636B (en) 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
US7090879B2 (en) * 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
AU2005321326B2 (en) 2004-12-27 2011-05-26 Société des Produits Nestlé S.A. Use of infant formula with reduced protein content
US20070281054A1 (en) * 2006-05-31 2007-12-06 Abbott Laboratories Organic powder nutritional formula containing select carbohydrate combinations

Also Published As

Publication number Publication date
TWI418308B (zh) 2013-12-11
JP2011507517A (ja) 2011-03-10
CN101998835A (zh) 2011-03-30
PE20091454A1 (es) 2009-10-25
WO2009085386A2 (en) 2009-07-09
AR069839A1 (es) 2010-02-24
HK1145275A1 (en) 2011-04-15
CO6280446A2 (es) 2011-05-20
EP2227099B1 (en) 2015-03-04
BRPI0823502A2 (pt) 2018-03-20
PA8808801A1 (es) 2009-07-23
DK2227099T3 (en) 2015-06-15
RU2010129985A (ru) 2012-01-27
CA2708272A1 (en) 2009-07-09
TW200934396A (en) 2009-08-16
ES2535144T3 (es) 2015-05-06
RU2479219C2 (ru) 2013-04-20
IL206200A (en) 2015-05-31
WO2009085386A3 (en) 2009-09-17
MX2010006891A (es) 2010-10-15
GT201000174A (es) 2012-04-03
DOP2010000174A (es) 2010-06-30
EP2227099A2 (en) 2010-09-15
ZA201004029B (en) 2011-04-28
NZ585574A (en) 2012-06-29
ECSP10010261A (es) 2010-07-30
AU2008343687A1 (en) 2009-07-09
CL2008003807A1 (es) 2009-10-16
CA2708272C (en) 2015-10-13
US20090162521A1 (en) 2009-06-25
MY150500A (en) 2014-01-30
US8361534B2 (en) 2013-01-29
IL206200A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
CR11509A (es) Polvo nutricional estable
CR11508A (es) Polvo nutricional estable
CR20110508A (es) Nuevos derivados de prolina como inhibidores de catepsina
UA117804C2 (uk) Темне кормове борошно каноли зі збільшеною харчовою цінністю
AR083720A1 (es) Formulaciones adhesivas de proteina con aditivos de epiclorohidrina e isocianato
BR112016028644A2 (pt) composições de célula t aprimoradas
PA8850201A1 (es) Combinaciones antitumorales que contienen anticuerpos
PA8850101A1 (es) Combinaciones antitumorales que contienen anticuerpos
CO6630181A2 (es) Composiciones y métodos para uso de anticuerpos terapéuticos de lrp6( proteina relacionada con lipoproteínas de baja densidad 6)
MX2015015234A (es) Composiciones y metodos para modular la expresion de la apolipoproteina (a).
ECSP11011417A (es) Anticuerpos anti-fgfr3 y métodos que los utilizan
MX2012006549A (es) Composiciones y metodos que comprenden variantes de proteasa.
MX2010006197A (es) Composicion nutricional enterica liquida con alto contenido de energia.
AR066042A1 (es) Moleculas y metodos para modular la proteina convertasa-subtilisina /quexina tipo 9 (pcsk9)
MX2010004113A (es) Composicion para regular el metabolismo de lipidos.
BR112014014834A2 (pt) composições para cuidado oral
EA201001845A1 (ru) Высокоэффективный антиокислитель на основе трегалулозы
AU201810529S (en) Lighting Module Heatsink
ECSP13013018A (es) Composiciones nutricionales fortificadas a base de leche
AR086239A1 (es) Composiciones que comprenden un antimetabolito de glucosa y selenio
MX377780B (es) Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes.
MX2018005277A (es) Modular la expresion de apolipoproteina (a).
PH12015500049B1 (en) Novel protein material
BR112022010141A2 (pt) Dispositivo shisha com calha
WO2012142256A3 (en) Modulators of mitochondrial protein import

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)